Katholisches Kinderkrankenhaus Wilhelmstift gGmbH

Hamburg 7 trials 4 recruiting

7 Registered trials

4 Currently recruiting

Organisation

Katholisches Kinderkrankenhaus Wilhelmstift gGmbH

Location

Hamburg, Germany

Identifier

ORG-100046969

Address

Liliencronstrasse 130, Rahlstedt, 22149, Germany

Departments

#0301:Pädiatrie und Päd. Dermatologie
#1203: Abteilungen für Pädiatrie und Pädiatrische Dermatologie
#40758: Dermatologie
Departments of Paediatrics and Paediatric Dermatology
Dermatologie
N/A
Pädiatrie und Pädiatrische Dermatologie / Allergologie

Clinical trials at this site (7)

Search interface

EPIK-P4: A Phase II single-arm study to assess the efficacy, safety and pharmacokinetics of alpelisib (BYL719) in pediatric and adult patien… Recruiting

2024-519960-42-00 PIK3CA-Related Overgrowth Spectrum (PROS) 4 2025-12-11
A study to evaluate the efficacy and safety of ruxolitinib cream in children (6 to <12 years old) with non-segmental vitiligo Recruiting

2024-513171-41-00 Vitiligo 5 2025-09-11
A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting

2023-503859-10-00 Moderate to Severe Plaque Psoriasis 5 2024-08-12
A Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to… Recruiting

2022-502519-13-00 Moderate to Severe Plaque Psoriasis 5 2021-05-07
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS) Ended

2022-502700-78-00 Alopecia areata (AA) 5 2023-09-01
A research study to find out if the study treatment alpelisib (BYL719) is safe and can help others who have confirmed diagnosis of PIK3CA-re… Ended

2023-508530-34-00 PIK3CA-Related Overgrowth Spectrum (PROS) 4 2021-04-19
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS) Ended

2023-503898-38-00 Atopic Dermatitis 5 2019-05-24